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Nitric oxide and glomerulonephritis. The glomerulus is a unique NO INDUCTION IN EXPERIMENTAL GN
vascular network with the potential to express several isoforms
Nephrotoxic nephritisof nitric oxide synthase (NOS). Induction of inducible NOS
(iNOS) occurs as part of a rapid initial response to immune There are two principal mechanisms operating to in-
injury in glomerulonephritis (GN). Studies on rodent models duce immune glomerular injury: antibody or cell media-
suggest that this is due to activation of transcription factors by tion. The various forms of nephrotoxic nephritis provide
reactive oxygen species (ROS), generated in responses to Fc
models of both these mechanisms.and CR engagement. iNOS operates in a complex milieu among
Accelerated nephrotoxic nephritis (ANTN) is the clas-multiple other inflammatory mediators, changing expression
of constitutive NOS (endothelial NOS, eNOS), a critical regula- sical model for studying cell-mediated immune injury.
tor of glomerular function, and auto-regulating its own expres- Rats are pre-immunized with foreign globulin, which
sion. As yet there is no consensus as to the role of high output leads to sensitization, followed by an injection of a ‘sub-
NO generated by iNOS in the glomerulus, although many stud-
nephritogenic’ dose of antibody with antiglomerularies have demonstrated that NO inhibition can alter the level
basement membrane (anti-GBM) activity from the im-of proteinuria and leukocyte infiltration, and other manifesta-
munizing species, which localizes the immune reactiontions of injury such as thrombosis, proliferation, and matrix
production. This article reviews the evidence accumulated from in the glomerular capillaries. Immune-activated macro-
experimental studies over the past decade, and discusses how phages infiltrate in response to the presence of sensitized
these conflicting data can be reconciled to form a working T cells, in a delayed-type-hypersensitivity reaction. Thehypothesis on the role of NO in GN.
macrophages are the effectors of proteinuria and other
structural damage, but how they do this has never been
clarified. The emerging evidence of NO as a major ef-The glomerulus is a unique vascular network with three
fector of macrophage cytotoxicity [2] stimulated us tospecialized cell types: the endothelial cell, the mesangial
look for NO production in macrophage-dependent GNcell, and the visceral epithelial cell. In the normal glomer-
[3]. The first study of generation of nitrite (NO2), a stableulus, of the three potential nitric oxide synthase enzymes
end product of NO, in the culture medium of isolated(NOSs), eNOS is constitutively expressed by the endothe-
glomeruli showed nephritic, but not normal, glomerulilium. Although amplification can detect inducible NOS
produced nanomolar amounts of NO2, which was linear(iNOS) transcripts it is controversial whether significant
over 48 hours, inhibited by L-NMMA, and this inhibitionprotein is present under basal conditions. We have shown
was reversed by l-arginine (Fig. 1). Studied at intervalsthat in the rat, high output NO, detectable as NO2, can be from 1 to 21 days after induction of disease, peak NO co-induced by lipopolysaccharide (LPS) ex vivo in the nor-
incided with the initial macrophage infiltrate, suggestingmal glomerulus in the population of MHC Class 2 ex-
macrophages were the source. This was further sup-pressing macrophages found resident in this species [1].
ported by the large amounts of NO2 produced by macro-Neuronal NOS (nNOS) is present at the macula densa.
phages extracted from the nephritic glomeruli by enzymicIn glomerulonephritis (GN) capillary inflammation is
digestion. Interestingly, later there was a rapid declineassociated with iNOS induction. My group was the first
in glomerular NO despite the persistence of the macro-to identify high output NO in GN due to iNOS induction,
phage infiltrate. Among the possible explanations for thisand this will be the focus of this article. The role of
action, the recent in vitro findings of Connelly et al ofeNOS is discussed in this Forefronts in Nephrology sym-
biphasic expression of iNOS in RAW cells are very simi-posium by Peter Heeringa (this issue, page 822).
lar, where high levels of NO negatively regulate iNOS
through inactivation of nuclear factor-B (NF-B) [4].
Further work on experimental GN has confirmed theKey words: nitric oxide, inflammation, kidney, proteinuria, glomerular
disease, injury, leukocyte infiltration. validity of our methods, and confirmed iNOS induction,
both message [5, 6] and protein [6] in ANTN. However, 2002 by the International Society of Nephrology
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Fig. 1. Generation of nitrite (NO2 ) by isolated glomeruli (gl) at inter-
vals from 1 to 21 days after induction of accelerated nephrotoxic nephri-
tis (ANTN). (A) Glomerular NO2 nm/2000 gl/48 h. The solid columns Fig. 2. Initial 24 hours after induction of heterologous nephrotoxic
() denote the macrophage (mø) numbers/gl. (B) Linear glomerular nephritis (HNTN). (A) Time course of leukocyte infiltration. Abbrevia-
NO2 over a 48-hour incubation period. (C) Inhibition of glomerular tions are: mø, macrophages (dashed line); pmn, neutrophils (solid line).
NO2 by increasing concentrations of L-NMMA (0 to 50 mol/L), re- (B) Glomerular NO2 generation and iNOS mRNA induction.versed by 0.4 mmol/L l-arginine.
lease. HNTN is initiated by a ‘nephritogenic’ dose offinding a role for iNOS has been problematic. In the
heterologous antibody with anti-GBM specificity. RapidANTN model, the iNOS knockout did not show any
GBM fixation causes PMN infiltration and protein-effects on proteinuria or histology [7], suggesting that
uria within two hours, resolving by 24 hours. This modelmacrophage-induced proteinuria is not due to NO and
was the first where NO inhibition was used to assess aits mechanism remains somewhat of a mystery. The ef-
role for NO [11]. Effects of infusion of the non-selectivefects of eNOS knockout in this model looks more signifi-
competitive NOS inhibitor NG-monomethy-l-argininecant [8], as further described in this by Peter Heeringa
(L-NMMA) in the initial two hours on proteinuria and(this issue, page 822). One possibility is that although
glomerular function were assessed using micropuncture.there is considerable NO produced, in vivo it is rapidly
There was a worsening of proteinuria and glomerularneutralized before it accumulates in cytotoxic amounts.
vasoconstriction, suggesting some protective role for NOThere are several potential reasons for this action. We
in opposing the increased vasoconstriction of the injuredlooked for mechanisms that might protect glomeruli
glomerulus. At that time, the differential effects of non-from the effects of iNOS activity and studied heme oxy-
selective NO inhibition were unknown. The current con-genase (HO), the rate-limiting enzyme in the catabolism
cept is that increased vasoconstriction may be due toof cellular hem. In ANTN there was induction of HO-1,
inhibition of eNOS. As Goligorsky and Noiri have re-and amelioration of proteinuria by the HO-1 inducer
cently stated: “When the functions of all NOS isoformshemin [9]. Lianos and colleagues have recently shown
are blocked, the deleterious effects of inhibiting eNOSthat HO-1 induction attenuates iNOS expression [10]
invariably prevail over the possible benefits of inhibitingand they discuss this and other aspects of the potential
iNOS” [12]. In addition, a loss of eNOS has been identi-relationship between NO and HO-1 in this issue (page
fied ultrastructurally in this model by immunogold label-847).
ing [13]. This latter study showed that the non-selectiveHeterologous nephrotoxic nephritis (HNTN) is the
competitive inhibitor NG-nitro-l-arginine methylesterclassical model for studying antibody-mediated, poly-
(L-NAME) prevented loss of eNOS and protectedmorphoneutrophil (PMN)-dependent GN. Depending
against macrophage infiltration but was without effecton the species, this PMN infiltration may be complement
on proteinuria. INOS-specific inhibition in the first 24dependent or independent; the principle way in which
hours of HNTN, when injury is fully PMN dependent,PMNs induce tissue damage is through reactive oxygen
species (ROS) generation and/or proteolytic enzyme re- was tested using l-iminoethyl lysine (L-NIL) [14]. At
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studies manipulating the dietary intake of the NO pre-
cursor l-arginine also have supported this finding [19].
The isoform of NOS involved has not been investigated.
Ishizuka et al found that iNOS inhibition (L-NIL) did
not affect mesangiolysis (abstract; J Am Soc Nephrol
10:513A, 1999), and we have also found this in unpub-
lished experiments. However, in a study of NO-regulated
genes in mesangial cells, Walpen et al have recently
published that in vivo L-NIL decreases the expression
of the neutrophil chemokine MIP-2 and the number of
infiltrating PMNs [20]. There was no comment on the
effect on mesangiolysis. A protective role for eNOS inFig. 3. Pattern of glomerular NO2 generation and histological changes
this model has been proposed from work showing thatin anti-Thy 1 GN. (a) Mesangiolysis, (b) aneurysm formation, (c) mesan-
gial proliferation are shown. agmatine, the l-arginine metabolite produced by argi-
nine decarboxylase, prevents the acute decrease in GFR
[15]. It also reduces mesangial proliferation and matrix
increase.
two hours after anti-GBM antibody administration at
peak PMN infiltration, there was iNOS mRNA induction Heymann nephritis
and NO2 production by nephritic glomeruli (Fig. 2). Al- There are leukocyte independent models of GN, and
though L-NIL inhibited glomerular NO2, there was no these should provide an opportunity to determine
effect on PMN infiltration and no consistent effects on whether NO production in vivo is always due to, or
proteinuria. This supports the previously established at least is always associated with, leukocytes. Heymann
concepts on mediation by PMNs in this model rather nephritis is one such model where subepithelial immune
than a cytotoxic effect of iNOS activity, although eNOS complexes forming in situ at the foot processes of visceral
activity may regulate the level of leukocyte infiltration epithelial cells trigger complement membrane attack
and glomerular thrombosis [8, 13]. complex leading to ROS-mediated glomerular basement
membrane (GBM) injury [21]. In the active form of this
Anti-Thy 1 glomerulonephritis model, induced by repeated immunization with the renal
This model of mesangial proliferative GN has at- tubular antigen Fx1A, we found a low level of NO pro-
tracted a number of NO studies, partly because it offers duction that was inhibited by prior bone marrow irradia-
the potential for examining an in vivo counterpart to the tion, suggesting that even in this model, infiltrating leu-
in vitro studies on the mesangial cell, and also because kocytes were a source of increased NO [22]. There have
mesangial proliferation is a common pathological change been studies in both the active and passive forms of
in human GN leading to chronic excess in mesangial Heymann nephritis using non-selective NO inhibition
matrix, the specialized form of glomerular scarring. Anti- (L-NAME), showing that there is a protective compo-
Thy 1 GN is induced by a dose of complement-fixing nent to NO generation in GN [23, 24].
antibody, either poly- or monoclonal, directed against
the Thy 1 antigen expressed on the mesangial cell mem- NO AND HUMAN GLOMERULONEPHRITIS
brane. It goes through three clear phases. Within hours,
Inducible NOS induction in glomeruli in human GNthere is destruction of mesangial cells with an acute in-
has been confirmed in renal biopsies. There are iNOSflammatory reaction; Ishizuka et al have shown a dra-
positive cells in glomeruli in proliferative forms of lupusmatic reduction in the glomerular filtration rate (GFR)
nephritis [25, 26] and IgA nephropathy [25], but notin this phase [15]. This is followed by microaneurysm
in non-proliferative diseases [25]. The localization byformation when the supporting core of the capillaries
immunohistochemistry in one study [25] suggested that,is lost. Mesangial proliferation, capillary regrowth, and
unlike the rodent models, iNOS was not expressed inmatrix production ensue in a reparative, resolving pro-
CD68 positive macrophages, and might be parenchymal.
cess. NO production in anti-Thy 1 GN peaks during In some diseases iNOS was mainly found in interstitial
mesangiolysis (Fig. 3) [16], with iNOS mRNA induction infiltrates [26, 27].
localized to infiltrating PMNs by double immunolabeling
[17]. There are also changes in eNOS mRNA [17]. In
MECHANISMS OF INOS INDUCTIONthe one published instance of NO inhibition preventing
IN GLOMERULONEPHRITISinjury in a model of GN, Narita et al reported that a
single injection of L-NMMA, one hour prior to antibody In models of acute GN iNOS mRNA induction is
rapid, within one to two hours of the initial immune insultadministration prevented mesangiolysis [18]. Several
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to the glomerulus. Our knowledge of the pathogenesis
of GN would predict that, as for murine macrophages,
NF-B would be the predominant transcription factor
activated by cytokines, or possibly Fc or complement
receptor engagement, or ROS generation, all of which
have been demonstrated to be signaling pathways in
mesangial cells in culture.
Nuclear factor-B activation has been found in glo-
meruli in HNTN [28], and Thy 1 GN [29]. In HNTN the
antioxidant pyrrolidine dithicarbamate inhibited several
NF-B–dependent genes, including iNOS [28]. Whether
this activation is cytokine dependent is less certain. Our
initial studies produced indirect evidence suggesting it
was (1) in vivo administration of interleukin-1 (IL-1)
to normal rats was able to induce iNOS mRNA expres-
sion [30], and (2) analysis of the earliest stages of anti-
Thy 1 showed that pro-inflammatory cytokine message
[for IL-1 and tumor necrosis factor- (TNF-)] pre-
ceded iNOS mRNA induction by 30 minutes [31]. How-
ever, the 2 agonist, Salbutamol, will also induce iNOS
in rat glomeruli when administered in vivo (S. Wad-
dington and J. Pfeilschifter, personal communication), Fig. 4. Effects of N acetyl cysteine (NAC) in anti-Thy 1 GN. (A)
indicating that the separate cAMP pathway of iNOS Glomerular iNOS mRNA induction at two hours, RT-PCR doubling
dilutions of template from 4 representative rats, 2 control and 2 NACinduction described in mesangial cells [32] can function
treated (B) glomerular NO2 generation [() NAC-treated, () con-in vivo. Furthermore, we studied ROS inhibition in anti- trols], (C) glomerular chemiluminescence (RLU  relative light units/
Thy 1 GN using the thiol radical scavenger N-acetylcys- 600 gl) over one hour incubation period [() NAC-treated, () con-
trols].teine (NAC) [33]. We found NAC suppressed glomeru-
lar iNOS induction, glomerular NO2 generation, and
glomerular radical production, as assessed by chemilumi-
under NO control [35], an array of potential conse-nescence (Fig. 4), without alteration in induced cytokine
quences, including subsequent negative regulation ofmRNAs. Soluble CR1 had the same effect [31]. These
iNOS to minimize further tissue damage.results dissociate cytokine induction from iNOS induc-
tion and suggest iNOS induction through ROS genera- Cell and matrix injury
tion, most probably initiated by complement activation.
The data predict local generation of cytotoxic levelsClearly this is a complex issue and induction mechanisms
of NO and concomitant O2 , which would result in perox-will vary with the pathogenesis of the model, the cell
ynitrite. However, there is only one report of injury beingtypes involved, and the stages of disease.
NO-dependent, in the anti-Thy 1 model [18], and in
macrophage-dependent GN, iNOS knockout did not
prevent injury [7]. Therefore, a role for NO in cell dam-ROLE OF NO IN GLOMERULONEPHRITIS
age still needs to be confirmed. The role of NO in glomer-A unifying concept of the role for iNOS has not
ular permeability has yet to be defined. Non-selectiveemerged from in vivo NO inhibition in models of GN.
NO inhibition increases albumin extravasation, possiblyFigure 5 summarizes the current evidence and indicates
through regulation of VEGF-dependent channels bypotential targets for the actions of NO in GN. Unques-
eNOS [36].tionably in both antibody- and cell-mediated GN models,
there is rapid induction of iNOS mRNA and iNOS pro- Cytokine expression
tein in glomeruli as part of the initial response to injury. Effects on regulation of cytokine expression have not
This may occur due to receptor engagement and ROS been defined. We found no effect of iNOS inhibition on
release. The level of NO production, and its duration, IL-1 or TNF- mRNA in anti-Thy 1 GN. However,
from ex vivo NO2 generation, appears to be cytotoxic/ iNOS inhibition has been shown to increase TH1 cyto-
cytostatic. Although in vivo there may be considerable kines in autoimmune interstitial nephritis [37].
neutralization, Heeringa et al have shown that it is suffi-
Leukocyte infiltration and activation: TH/TH2cient to produce detectable nitrotyrosine residues [34].
There follows a suppression of eNOS [8, 13, 34] and, On balance, there is good evidence that eNOS protects
against leukocyte infiltration. This may be partly throughgiven the increasing number of genes identified as being
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Fig. 5. Summary of induction of nitric oxide
(NO) synthesis and its potential roles in glo-
merulonephritis.
suppressing chemokine and adhesion molecule expres- Metabolic pathways of L-arginine
sion. In some situations iNOS also may do this, as shown Other pathways of l-arginine metabolism may be in-
by the effects of L-NIL in anti-Thy 1 GN [20], although fluenced not only by the level of available l-arginine,
we have not found this in ANTN [7] or HNTN [14]. but also by intermediates of the NO pathway. They may
The effects of NO on the afferent limb of the immune also interact with l-arginine metabolism via NOS. Ag-
reaction in acute GN have not been studied. This may matine, the product of arginine decarboxylase activity,
be more relevant to chronic GN, and is discussed in this can reduce the production of NO, and when adminis-
issue by Gary Gilkeson (this issue, page 839). tered in the anti-Thy 1 model, reduced mesangial prolif-
eration and the matrix increase [15]. The role of arginase,
Apoptosis which produces urea and ornithine from l-arginine is
There are no in vivo GN data so far. discussed in this Forefronts issue by Simon Waddington
(this issue, page 876).
Proliferation/matrix increase
Reducing NO in the anti-Thy 1 model will ameliorate
CONCLUSIONmesangial proliferation and matrix increase [18, 19].
Chatziantoniou et al, in a study of procol2 transgenic It has probably been more difficult to define roles for
NO in GN than in most other immune and inflammatorymice, reported that NO suppresses col 1 gene expression
in glomeruli [38]. diseases, despite a wealth of in vitro data. One difficulty
in interpreting in vivo data is the ambiguity due to the
Hemodynamics use of non-isoform specific NOS inhibitors, as is empha-
sized by other authors in this Forefronts in NephrologyFunctional eNOS appears critical for opposing the en-
Symposium. In addition, there is the particular depen-hanced vasoconstrictor activity that leads to the reduc-
dence of glomerular pathology on vasomoter tone. Hope-tions in GFR in GN. Most studies using non-selective
fully, a new stage has been reached, with greater aware-NO inhibitors have produced systemic and glomerular
ness of the complexity of the interaction between thehypertension with worsening of proteinuria. There seems
different NOS isoforms and the dependency of actionsno current explanation, other than inhibition of eNOS,
of NO on its amount and kinetics.as to why the NO produced by iNOS apparently does
not act as a sufficiently potent vasodilator, and this topic
is discussed by other authors in this Forefronts issue. ACKNOWLEDGMENTS
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